Flagship Harbor Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-60
Closed -$1K 1915
2019
Q2
$1K Hold
60
﹤0.01% 1784
2019
Q1
$1K Hold
60
﹤0.01% 1763
2018
Q4
$1K Hold
60
﹤0.01% 1749
2018
Q3
$2K Hold
60
﹤0.01% 1914
2018
Q2
$2K Buy
+60
New +$2.13K ﹤0.01% 1860

Other funds holding LMAT

Flagship Harbor Advisors's LMAT Position: Q3 2019 in Review

Flagship Harbor Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2019, closing a stake of 60 shares — an estimated $1K sold.

Flagship Harbor Advisors first reported a position in LMAT in Q2 2018 and held it in 5 quarters. The position peaked at $2K in Q3 2018. 145 funds tracked by Wall St. Rank hold LMAT as of Q3 2019.

  • Flagship Harbor Advisors reported no remaining LeMaitre Vascular position as of Q3 2019 after selling out during the quarter.
  • Flagship Harbor Advisors sold 60 LeMaitre Vascular shares in Q3 2019, an estimated $1K.
  • Flagship Harbor Advisors first reported a position in LeMaitre Vascular in Q2 2018 and held it in 5 quarters.
  • Flagship Harbor Advisors's LeMaitre Vascular position peaked at $2K in Q3 2018.
  • 145 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2019.

Based on Flagship Harbor Advisors's 13F filing for Q3 2019, filed 22 Oct 2019.